The three papers that follow have been chosen to reflect aspects of multimodality treatment ofchildren with attentiondeficit hyperactivity disorder (ADHD). For most of these children, medication without psychological intervention with the child and family is insufficient to influence any long term outcome.
Dr. Simeon ably reviews pharmacotherapy for children with ADHD. This will be welcomed by clinicians treating these children, particularly as the issues of "which medication," "for whom," "in what doses" are constantly in a state of change as new studies emerge.
Dr. Cousins's review of parent training and social skill training for children with ADHD discusses these two important therapies, which are usually a part of multimodal treatment of children with ADHD. Dr. Cousins's paper is original in its emphasis on the need to coordinate these two treatment modalities so that parents can learn to help their children to socialize more competently, so that skills learned can generalize to other situations. Together with other experienced clinicians, Dr. Cousins also emphasizes the need to ensure that parents are active, not passive recipients of information and skills in parent training groups, to ensure more lasting effects and even compliance in learning.
Finally, Dr. Hechtman, the first Canadian Principal Investigator of a collaborative Multimodality Treatment Program (to assess whether or not the latter is superior to medication alone for children with ADHD), shares with us the complexities of treatment outcome research, and best of all lets us know that this kind of study, which is so needed in the area of ADHD, is indeed feasible to carry out. Attention-deficit hyperactivity disorder, characterized by poor sustained attention, diminished impulse control and excessive physical activity, is found in most cultures and most countries. However, diagnostic terminology and management vary from centre to centre. Pharmacotherapy in conjunction with individual and family therapy is generally accepted as the most effective treatment, while psychostimulants are the drug of choice. 
